Clinical Trial

Implementation of a Diabetic Foot Prevention Strategy in Primary Care (iMplanta Study)

Study acronym: iMplanta
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 29, 2025 (before its estimated December 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this two-arm cluster randomised controlled trial (RCT) is to evaluate the effectiveness of a new implementation strategy based on the ImM model for the Protocol of assistance to the person with diabetic foot (PAPDF) of the Balearic Islands Health Service in reducing complications of diabetic foot, compared to the current implementation strategy, in the primary care centers of Majorca. As secondary objectives we aim 1. To determine the reach of the implementation strategy in the GAPM primary care centers, 2.To compare the effectiveness of the PAPDF versus usual care in preventing diabetic foot complications, 3. To identify the number of healthcare professionals adhering to the implementation strategy and 4. To assess the sustainability of the implementation strategy over time.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-26.
Trial Details
NCT Number NCT07004179
Lead Sponsor University of the Balearic Islands
Collaborators: Universitat de les Illes Balears
Conditions Diabetic Foot Disease, Diabetic Foot Ulcer (DFU)
Enrollment 1,520 participants
Start Date 2025-09-01
Primary Completion 2025-12-22 (estimated)
Study Completion 2026-12-22 (estimated)
Updated on ClinicalTrials.gov 2025-06-29